Since NT-proBNP is the main index of risk stratification for predicting the annual death rate of patients with PAH and right heart dysfunction, we also assessed the diagnostic efficacy of PAH-CHD from CHD for the metabolites primarily responsible for determining the patients in medium to high risk with NT-proBNP more than 300 pg/mL. Here, NPPB is linked to coronary artery disorder.